Related Experiment Videos
Post-ERCP pancreatitis in pediatric patients
Corey W Iqbal1, Todd H Baron, Christopher R Moir
1Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA.
Insights
Post-ERCP pancreatitis is uncommon, affecting 2.5% of patients without chronic pancreatitis. Therapeutic procedures and chronic pancreatitis increase the risk of this complication.
Area of Science:
- Gastroenterology
- Pediatric Endoscopy
Background:
- Pancreatitis is a recognized complication following endoscopic retrograde cholangiopancreatography (ERCP).
- Assessing the incidence and severity of ERCP-associated pancreatitis is crucial for patient safety.
Purpose of the Study:
- To determine the prevalence and severity of pancreatitis after ERCP in pediatric patients.
- To identify risk factors associated with post-ERCP pancreatitis.
Main Methods:
- Retrospective review of pediatric patients (<18 years) who underwent ERCP.
- Utilized the 1991 consensus statement criteria for diagnosing post-ERCP pancreatitis.
- Analyzed risk factors, including chronic pancreatitis and pancreatic duct stenting.
Main Results:
- Overall prevalence of post-ERCP pancreatitis was 2.5% in patients without chronic pancreatitis (7/276 ERCPs).
- Prevalence was higher (14.9%) in patients with chronic pancreatitis (10/67 ERCPs).
- Diagnostic ERCPs were associated with a lower risk of pancreatitis (P<0.01), while pancreatic duct stenting was a risk factor in chronic pancreatitis patients (P=0.02).
Conclusions:
- Post-ERCP pancreatitis prevalence is low (2.5%) when excluding patients with chronic pancreatitis.
- Therapeutic ERCP procedures and the presence of chronic pancreatitis are identified as risk factors for developing pancreatitis.
Objectives:
Pancreatitis is a known complication of endoscopic retrograde cholangiopancreatography (ERCP). Our aim was to assess the prevalence and severity of ERCP-associated pancreatitis using established criteria.
Materials And Methods:
Retrospective review of patients younger than 18 years undergoing ERCP complicated by post-ERCP pancreatitis defined by the 1991 consensus statement. Patients with chronic pancreatitis were studied separately using modified criteria. Risk factors for post-ERCP pancreatitis were analyzed.
Results:
Three hundred forty-three ERCPs were performed in 224 patients. Two hundred seventy-six ERCPs were performed in patients without chronic pancreatitis, 7 of which were complicated by post-ERCP pancreatitis (prevalence 2.5%). Patients undergoing diagnostic-only ERCP were less likely to develop post-ERCP pancreatitis (P<0.01). Sixty-seven procedures were performed on patients with chronic pancreatitis; 10 developed postprocedure pain requiring or prolonging hospitalization (prevalence 14.9%). Pancreatic duct stenting was a risk factor for post-ERCP pain in this subset of patients (P=0.02).
Conclusions:
The prevalence of post-ERCP pancreatitis is low-2.5% excluding patients with chronic pancreatitis and 4.96% overall. Therapeutic procedures and the presence of chronic pancreatitis are risk factors for post-ERCP pancreatitis.
Related Concept Videos
Endoscopic Procedures V: ERCP
Patient...
Acute Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis I: Introduction